Erectile dysfunction among male heroin addicts receiving methadone maintenance treatment in Guangdong, China

Journal of Addiction Medicine

Volumn 6, Issue 3, 2012, Pages 212-218

  Chen, Wen ^a   Li, Xin ^a   Li, Xiaoming ^b   Ling, Li ^a,c   Xia, Yinghua ^a   Chen, Jun ^a   He, Qun ^d  

^a Faculty of Medical Statistics and Epidemiology   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

China; Erectile dysfunction; Heroin addiction; Methadone maintenance treatment (MMT)

Indexed keywords

ALCOHOL; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; METHADONE; PROLACTIN; TESTOSTERONE;

ADULT; AGE; AGED; ANXIETY; ARTICLE; CHINA; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DRUG USE; ERECTILE DYSFUNCTION; FOLLOW UP; HEROIN DEPENDENCE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; METHADONE TREATMENT; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SUBSTANCE ABUSE; TOBACCO; TREATMENT DURATION;

ADULT; CHINA; COMORBIDITY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERECTILE DYSFUNCTION; HEROIN DEPENDENCE; HUMANS; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; RISK FACTORS; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84871336813     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318259b2c4     Document Type: Article

References (41)

1. Bai X, Liu N, Jia W, Zhang X. Study on sexual function of male MMT patients. Chin J Drug Abuse Prev Treat 2009;15:158-160.
2. Bell J, Hall W, Byth K. Changes in criminal activity after entering methadone maintenance. Br J Addict 1992;87:251-258.
3. Brown RT, Balousek S, Mundta M, Fleming M. Methadone maintenance and male sexual dysfunction. J Addict Dis 2005;24:91-106.
4. Brown RT, Zueldorff M. Opioid substitution with methadone and buprenorphine: sexual dsyfunction as a side effect of therapy. Heroin Addict Relat Clin Probl 2007;9:35-44.
5. Carson CC. Erectile dysfunction: evaluation and new treatment options. Psychosomat Med 2004;66:664-671.
6. Chun J, Carson CC. Physician patient dialog and clinical evaluation of erectile dysfunction. Urol Clin N Am 2001;28:249-258.
7. Cicero TJ, Bell RD, Wiest WG, Allison JH, Polakoski K, Robins E. Function of the male sex organs in heroin and methadone users. N Engl J Med 1975;292:882-887.
8. Cushman PJ, Kreek MJ. Methadone-maintained patients. Effect of methadone on plasma testosterone, FSH, LH, and prolactin. N Y State J Med 1974;74:1970-1973.
9. Deglon JJ, Martin JL, Imer RL. Methadone patients' sexual dysfunctions: clinical and treatment issues. Heroin Add Rel Clin Probl 2004;6:17-26.
10. Dole VP, Nyswander M. Methadone maintenance 4 decades later thousands of lives saved but still controversial. JAMA 2008;300:2303-5.
11. Ferrari A, Coccia C, Bertolini A, Sternieri E.Methadone-metabolism, pharmacokinetics and interactions. Pharmacol Res 2004;50:551-9.
12. Hanbury R, Cohen M, Stimmel B. Adequacy of sexual performance in men maintained on methadone. Am J Drug Alcohol Abuse 1977;4:13-20.
13. He Q, Wang XR, Xia YH, et al. New community-based methadone maintenance treatment programs in Guangdong, China, and their impact on patient quality of life. Subst Use Misuse 2011;46:749-757.
14. Jiang H, Zhu JC. Chinese men's attitudes to life events and sexuality: prevalence of erectile dysfunction and related health concerns among Chinese men in Asian males study. Natl J Androl 2006;12:1048-1052.
15. Lafisca S, Bolelli G, Franceschetti F, Filicori M, Flamigni C, Marigo M. Hormone levels in methadone-treated drug addicts. Drug Alcohol Depend 1981;8:229-234.
16. Langendam MW, van Brussel GH, Coutinho RA, van Ameijden EJ. The impact of harm-reduction-based methadone treatment on mortality among heroin users. Am J Public Health 2001;91:774-780.
17. Liang CZ, Zhang XJ, Hao ZY, Shi HQ, Wang KX. Prevalence of sexual dysfunction in Chinese men with chronic prostatitis. BJU Int 2004;93:568-570.
18. Liang KY, Zeger SL. Longitudinal data analysis using generalized linear models. Biometrika 1986;73:13-22.
19. Ministry of Health China, Ministry of Security China, State FDA China. National Guideline of Community-based Methadone Maintenance Treatment to Opioid-addicts in China. Beijing: Ministry of Health China Publication No. (2006)256:2006.
20. Morales A, Johnston B, Heaton JP, Lundie M. Testosterone supplementation for hypogonadal impotence: assessment of biochemical measures and therapeutic outcomes. J Urol 1997;157:849-854.
21. National Institute on Drug Abuse. Methadone Maintenance Treatment: Translating Research Into Policy. Bethesda, MD: Department of Health and Human Services, 1995.
22. National Institutes of Health. NIH Consensus development panel on impotence. JAMA 1993;270:83-90.
23. Quaglio G, Lugoboni F, Pattaro C, Melara B, Mezzelani P, Des Jarlais DC. Erectile dysfunction in male heroin users, receiving methadone and buprenorphine maintenance treatment. Drug Alcohol Depend 2008;94:12-18.
24. Ragni G, DeLauretis L, Bestetti O, Sghedoni D, Gambaro V. Gonadal function in male heroin and methadone addicts. Int J Androl 1988;11: 93-100.
25. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena B. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-326.
26. Safarinejad MR, Hosseini S. Erectile dysfunction: clinical guidelines (1). Urol J 2004;1:133-147.
27. Sbrocco T,Weisberg RB, BarlowDH, CarterMM.The conceptual relationship between panic disorder and male erectile dysfunction. J Sex Marital Ther 1997;23:212-220.
28. Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int J Impot Res 2003;15:S9-S13.
29. Slag MF,Morley JE, ElsonMK, et al. Impotence in medical clinic outpatients. JAMA 1983;249:1736-1740.
30. Smith DE, Moser C, Wesson DR, et al. A clinical guide to the diagnosis and treatment of heroin-related sexual dysfunction. J Psychoactive Drugs 1982;14:91-99.
31. Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate-vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA 1999;281:1000-1005.
32. Teusch L, Scherbaum N, Bohme H, Bender S, Eschmann-Mehl G, GastparM. Different patterns of sexual dysfunctions associated with psychiatric disorders and psychopharmacological treatment. Results of an investigation by semistructured interview of schizophrenic and neurotic patients and methadone-substituted opiate addicts. Pharmacopsychiatry 1995;28:84-92.
33. Van den BrinkW, Haasen C. Evidenced-based treatment of opioid-dependent patients. Can J Psychiatry 2006;51:635-646.
34. Wang P, Zhu JH, Yan J, Wang CH, Xu HM. Study of conditions of sexual function in male patients by MMT. Chin J Hum Sexual 2007;16:19-36.
35. Ward J, Mattick RP, Hall W. The effectiveness of methadone maintenance treatment: an overview. Drug Alcohol Rev 1994;13:327-335.
36. Wilczek H,Vesely Z, Presl J. Long-termfollow-up of the health status of opiate abusers treated with methadone-pilot study. Cas Lek Cesk 2002;141:393-397.
37. Willenbring ML, Morley JE, Krahn DD, Carlson GA, Levine AS, Shafer RB. Psychoneuroendocrine effects of methadone maintenance. Psychoneuroendocrinology 1989;14:371-391.
38. Woody G, McLellan AT, O'Brien C, et al. Hormone secretion in methadonedependent and abstinent patients. NIDA Res Monogr 1988;81:216-223.
39. Yin WY, Hao Y, Sun XH, et al. Scaling up the national methadone maintenance treatment program in China: achievements and challenges. Int J Epidemiol 2010;39: 1129-1137.
40. Zung WWK. A rating instrument for anxiety disorders. Psychosomatics 1971;12:371-379.
41. Zung WWK. From art to science: the diagnosis and treatment of depression. Arch Gen Psychiatry 1973;29:328-337.